RECAP DAVA Hawaii Lung 2026 — top KOL voices, trial buzz & every conference slide, decoded View Full Coverage →
KOL Pulse Insights Blog

Oncology KOL Intelligence, decoded.

Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.

3Articles
WeeklyNew insights
500+Verified oncologists tracked
0 articles · All topics
Using AI to Understand ivonescimab - KOL Pulse AI Demo
Feb 11, 2025 8:19:45 AM Brian Shields

Using AI to Understand ivonescimab - KOL Pulse AI Demo

Akeso biopharma published a preprint of the mechanism of action of ivonescimab. Can the KOL Pulse AI provide context to KOL questions about HARMONi-A?

KOLasco24Key Opinion Leader
HARMONi-2 Trial: Ivonescimab vs. Pembrolizumab
Nov 6, 2024 4:05:10 PM Brian Shields

HARMONi-2 Trial: Ivonescimab vs. Pembrolizumab

On September 8th, HARMONI-2 trial data will be presented at World Lung by Akeso. In 2022, Summit, founded by Bob Duggan, bet $500M Cash and $5B Total that ivone…

WCLC24
The Wild West of World Lung Cancer #WCLC24
Sep 5, 2024 5:01:00 AM Brian Shields

The Wild West of World Lung Cancer #WCLC24

On September 8th, HARMONI-2 trial data will be presented at World Lung by Akeso. In 2022, Summit, founded by Bob Duggan, bet $500M Cash and $5B Total that ivone…

AIWCLC24

Track the KOLs shaping oncology

KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.

Book a Demo Back to Homepage